Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Investment in Unconsolidated Subsidiaries (Details Textual)

v3.5.0.2
Note 4 - Investment in Unconsolidated Subsidiaries (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2016
USD ($)
$ / item
Jun. 30, 2014
USD ($)
$ / shares
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
Milestone China [Member] | Instruments and Handpieces [Member]              
Cost of Goods Sold         $ 3,203,466    
Milestone China [Member] | STA Instruments and Handpieces [Member]              
Accounts Receivable, Related Parties     $ 1,850,200   1,850,200    
Milestone China [Member]              
Equity Method Investments   $ 1,000,000 0   0   $ 0
Equity Method Investment, Ownership Percentage   40.00%          
Cost-method Investments, Realized Losses         405,205    
Long-term Purchase Commitment, Minimum Quantity Required 308 772          
Distributor Price Per Instrument | $ / shares   $ 1,296          
Long-term Purchase Commitment, Amount $ 400,000            
Long-term Purchase Commitment, Amount per Instrument | $ / item 1,296            
Additional Equity Method Investments $ 165,000            
Income (Loss) from Equity Method Investments     $ (253,451) $ (123,083) (554,766) $ (187,062)  
Equity Method Investment, Unrealized Intercompany Profit (Loss) Not Eliminated, Amount         $ 381,113    
Advanced Ocular Sciences SA [Member]              
Equity Method Investment, Ownership Percentage     25.00%   25.00%    
Advances to Affiliate             $ 78,798
Write-off of Advances to Affiliate         $ 78,798    
Cost-method Investments, Realized Losses         19,700    
Income (Loss) from Equity Method Investments     $ (253,451) (711,352) (554,766) (1,759,266)  
Cost of Goods Sold     $ 1,517,561 $ 794,285 $ 3,675,552 $ 2,298,162